Don Davis PhD, MBA

Digital Marketer & Process Improvement NERD - I help companies improve their systems and processes, amplify their voice, increase awareness and drive leads.

Most B2B marketing generates noise. Ours generates pipeline.

I help High Tech and Life Sciences CEOs cut through the chaos and build marketing systems that predictably convert visibility into qualified leads—without the guesswork.

After decades leading digital strategy and P&L in life sciences and operations, I've seen the same pattern: smart teams drowning in tactics that look busy but don't move numbers. They chase trends. We build engines.

Here's what I know: Your buyers aren't hiding. They're ignoring you because your marketing doesn't earn their time.

That's why I founded D3 Digital Media Marketing and created WAVES—a retained, end-to-end growth system designed for B2B companies scaling to $250M. We don't do campaigns. We build compounding systems that create sales conversations.

The WAVES framework (simplified):

• Website as a sales tool – Clear messaging, zero friction, built to convert
• Advanced SEO – Own buyer intent. 2-3x traffic that actually qualifies
• Video + live events – Turn your experts into demand generators
• Social that sells – Content that starts conversations with decision-makers, not engagement farmers
• Strategic PR – Credibility where it counts

Every 90 days, we measure what moves pipeline and eliminate what doesn't. No vanity metrics. No "let's try this." Just disciplined execution and clear ROI.

Why clients choose us: They arrive overwhelmed by options and underwhelmed by results. They leave with a system that compounds—attention that turns into appointments, content that builds trust, and marketing that finally justifies its budget.

If you're a CEO or CMO tired of marketing theater and ready for marketing that funds itself, let's map your next 90 days. I'll show you exactly where the gaps are and how we'll fill them.

📩 Message me. Let's turn your visibility into revenue.

Founder

We help our clients amplify their voice so that they can: create well qualified leads, increase awareness and attract investors.

Catalyst Pharmaceuticals, Inc.

Field Medical Affairs

Biogen

Contributed to the development and execution of US medical strategy and tactics for Neuromuscular Rare Disease. 
Developed external medical education content for field medical implantation.
Participated on workstreams to develop AI integration into digital systems for field implantation.
Promotional medical reviewer.
Lead and moderated advisory and steering committee meetings.
Collaborated on various initiatives with cross-functional partners across  and upon multiple levels of the organization.
Supported late phase clinical trials.
Led Congress strategy and tactics.

Associate Medical Director Rare Neuromuscular Disease (through October 2023) 

MSL lead for intrathecal device development for optimizing delivery of CNS Antisense oligonucleotides.
Initiated and co-moderated two intrathecal drug delivery ad boards, and SMA Pediatric/Adult Neurology multidisciplinary ad board.
Developed Medical education forums and identified key experts and topics for online programs.
Identified and developed relationships with Key Medical Experts and Health Care Providers at all levels in medical field.
MSL Lead for KME Engagement platform development, the platform will be utilized across the organization.
Medical reviewer for Promotional review committee.
Mentoring peers to go beyond the data presentation (transaction) to develop long-term active KME relationships (relational).
Onboarding of New MSLs and mentorship of MSL who come into company with limited experience.
Recognized and nominated by peers to receive Biogen 2018 Business Innovation Award.
Dare to Be Great Fearless Factor Award- SMA Team Collaboration Award.

Sr Medical Science Liaison Rare Disease Spinal Muscular Atrophy 

Sanofi Genzyme

Supported field medical affairs for end-of-life cycle rare disease thyroid cancer therapies. 
Developed key medical expert relationships in endocrinology, nuclear medicine, and radiation oncology.
Onboarding and mentoring of New MSL that come to us from medical information department. 
Congress planning for the Rare Disease MSL Team. 
Co-moderated with KMEs, multiple medical round table programs for endocrinologist, and imaging specialist which was the main KPI for the team.

Sr Medical Science Liaison Rare Disease Endocrine

Jazz Pharmaceuticals

Co-developed open label registry study and case report forms with medical director that was successfully implementing resulting in a great amount of data generation.
Collaborated with Clinical Research Organization to assist clinical sites with study start up documentation.
Developed customized medical letters for health care provider queries. 
Onboarded and mentored New MSLs joining the team.
Developed and coordinated education programs for internal medical, R&D and Sr level commercial colleagues. (Annual Pain Summit). 
Developed and Conducted Research Advisory Board. 
Budget impact modeling for intrathecal delivered pain product, clinical dossier update.
Lead MSL on publication strategy.
Developed and maintained long term- active peer to peer KME relationships.

Senior Medical Science Liaison- Pain 

Azur Pharma

Senior MSL for Prialt (ziconotide intrathecal infusion) for severe chronic pain. Territory West/Central. Prialt was divested from Elan

Senior Medical Science Liaison- PAIN

Elan

Worked at the above three companies supporting field medical affairs for same therapeutic intrathecal pain therapy (Elan divested to Azur, Jazz acquired Azur).
Promoted to Senior level MSL after 3 years with Elan.

Senior Medical Science Liaison-PAIN

Lifetree Pain Clinic

Expertise in intrathecal drug delivery
Initiated, administered, monitored, and assessed drug therapy in complex chronic pain management population. 
Developed clinical expertise in intrathecal drug delivery in pain management. 
Provided Clinical drug updates in services to healthcare provider staff. 
Maintained blind on clinical trials phase. 
Dispensed study drug and maintained all required study documents. 
Designed clinical trials for small pharmaceutical companies. 
Designed study protocol for a quantitative opioid urine drug screen that is not used in clinical practices around the nation.
Precepted pharmacy students from regional pharmacy schools for their advanced specialty clinical rotation, one pharmacy student ended up becoming an investigator pharmacist and later went in-to industry. 
Publications and CME development in Pain Management.

Pain Managment Clinical Pharmacist

University of Utah Hospitals and Clinics

2 year postdoctoral fellowship in Pain Management and Palliative Care

PharmD

As an Associate Medical Director at Biogen, I contributed to the medical strategy and execution for the neuromuscular disease portfolio, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). I have over 16 years of tenure in the pharmaceutical industry, supporting complex intrathecal therapeutics in rare neuromuscular diseases and pain management.

My clinical and industry experience enables me to build and maintain strong peer-like relationships with thought leaders, clinical investigators, and key stakeholders in the neuromuscular disease community. I also have a strong clinical research acumen in pain and CNS therapeutics, having been involved in multiple clinical trials, publications, and medical education initiatives. My mission is to advance the science and improve the lives of patients with rare diseases of the CNS, leveraging many facets of my broad experience.

taplio

The Battle

Don Davis PhD, MBA

Keri Kasun, PharmD

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?